Share Twitter LinkedIn Facebook Email Robert Rifkin, MD, FACP, Attending Physician, Department of Cellular Therapy, Presbyterian/St. Luke"™s Medical Center, explains the role of daratumumab as a maintenance therapy in the management of multiple myeloma (MM).